(Q47262616)

English

Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate (English)

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

R Rau

1

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

S Simianer

2

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

P L C M van Riel

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

L B A van de Putte

4

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

K Krüger

5

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

M Schattenkirchner

6

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

C F Allaart

7

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

F C Breedveld

8

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

J Kempeni

9

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

K Beck

10

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

H Kupper

11

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

publication date

1 January 2004

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

Scandinavian Journal of Rheumatology

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

33

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

3

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

145-153

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation.

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://api.crossref.org/works/10.1080%2F03009740410005467

21 January 2018

Identifiers

10.1080/03009740410005467

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

release_43erragxsffhdo4ipvoym6vriy

1 reference

https://api.fatcat.wiki/v0/release/43erragxsffhdo4ipvoym6vriy

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 January 2018

http://europepmc.org/abstract/MED/15228184

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47262616&oldid=2148348543"